A new medication proved effective in slowing the spread of metastatic prostate cancer, while helping to maintain the quality of life, in patients with advanced disease. The phase 3 study was unblinded midway, allowing patients receiving the placebo to instead take the drug because of the...
Zytiga (abiraterone acetate), an ingested pill treatment manufactured by J&J, has been found to potentially extend life by up to four months in men with spreading cancer who have already been treated with chemotherapy. However, there are other altervatives if so desired. According to the...